45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Ralph P. Ermoian, John Breneman, David O. Walterhouse, Yueh Yun Chi, Jane Meza, James Anderson, Douglas S. Hawkins, Andrea A. Hayes-Jordan, David M. Parham, Torunn I. Yock, Sarah S. Donaldson, Suzanne L. Wolden

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of '45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group'. Together they form a unique fingerprint.

Medicine & Life Sciences